The luster is starting to wear off GLP-1 weight-loss drugs including Wegovy and Ozempic as more clinicians warn patients ...

Here is more information on Wegovy, how to decide if it’s right for you, and what you need to know about the Wegovy ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring ...

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to focus on GLP-1 products.

Britain’s pharmacists have called for tougher regulation of weight-loss drugs after ... Wegovy or Mounjaro. It added that a patient’s medical history should also be examined and regular ...

Oil and gold futures are higher. U.S.-listed shares of Ozempic and Wegovy maker Novo Nordisk (NVO) are jumping 14% in premarket trading after the Danish drugmaker reported positive Phase 1b/2a ...

After all, their opinions are (or at least, should be) based on a thorough review of the underlying ... has plunged nearly 30% below its high set before the U.S. elections in November 2024.

He spoke on the chances of getting popular weight loss drugs like Saxenda and Wegovy covered again for state employees, future premium increases and more. Briner announced soon after taking office ...

Opens in a new tab or window Patients treated with semaglutide 7.2 mg achieved a 20.7% weight loss after 72 weeks compared with a reduction of 17.5% with semaglutide 2.4 mg (Wegovy) and 2.4% with ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...